Liposoluble vitamins in patients receiving long-term octreotide treatment

Liposoluble vitamins in patients receiving long-term octreotide treatment - Liposoluble vitamins during octreotide treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32903

Enrollment

Registered

2009-01-12

Start date

2008-12-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liposoluble vitamin deficiency shortage of liposoluble vitamins

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: octreotide-treatment longer than 18 months

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Patients will be investigated for vitamin-status by measuring liposoluble vitamins, relevant lipid components and relevant biochemical investigations to measure effects of possible vitamin deficiency, including calciumlevels, PTH and coagulation in blood	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results